HR3164-119

Reported

Ensuring Community Access to Pharmacist Services Act

119th Congress Introduced May 1, 2025

Summary

What This Bill Does

The Ensuring Community Access to Pharmacist Services Act creates a new Medicare Part B benefit for pharmacist services. It amends Social Security Act section 1861 so a pharmacist can be paid for services and incident-to supplies that would otherwise be covered if furnished by a physician, as long as the pharmacist is legally authorized under State law and follows any State supervision or collaboration requirement. The covered services include evaluation and management visits for testing or treatment of COVID-19, influenza, respiratory syncytial virus, and streptococcal pharyngitis, plus testing or treatment services tied to a public health emergency declared under Public Health Service Act section 319. Payment is generally set at 85 percent of the physician fee schedule amount, while public-health-emergency services are paid at 100 percent.

Who Benefits and How

Pharmacist service providers benefit because Medicare Part B would recognize a new paid clinical service category for disease testing, treatment, and emergency-response services. Pharmacy business owners benefit from a new reimbursement stream for state-authorized clinical work that may already occur in community pharmacies. Medicare beneficiaries benefit from more access points for common infectious-disease evaluation and treatment, especially where physician appointments are scarce. Rural Medicare patients and underserved communities benefit if pharmacies can provide quicker testing and treatment access. Public health agencies benefit from a larger clinical workforce during declared emergencies.

Who Bears the Burden and How

The Medicare Part B program and Federal taxpayers bear new payment costs for pharmacist-provided services. The Centers for Medicare and Medicaid Services must implement coverage, billing, supervision, collaboration, and payment rules. Pharmacists must stay within State scope-of-practice law and comply with any physician-supervision or collaboration conditions. Primary care physician practices may lose some routine infectious-disease visits to pharmacy settings. Medicare claims contractors must process and police the new service category.

Key Provisions

  • Adds pharmacist services to the Medicare Part B list of covered medical and health services.
  • Defines covered pharmacist services as state-authorized services and incident-to supplies that would otherwise be covered if furnished by a physician.
  • Provides coverage for evaluation, testing, and treatment of COVID-19, influenza, RSV, and strep throat.
  • Provides coverage for testing or treatment services connected to declared public health emergencies.
  • Sets payment at 85 percent of the physician fee schedule amount, or 100 percent for public-health-emergency services.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Adds pharmacist services to Medicare Part B coverage when pharmacists provide state-authorized evaluation, testing, treatment, and related supplies for COVID-19, influenza, RSV, strep throat, or public-health-emergency services, with payment tied to the physician fee schedule.

Key Policy Areas

Medicare, Pharmacy, Public Health

Primary Purpose

Adds pharmacist services to Medicare Part B coverage when pharmacists provide state-authorized evaluation, testing, treatment, and related supplies for COVID-19, influenza, RSV, strep throat, or public-health-emergency services, with payment tied to the physician fee schedule.

Policy Domains

Medicare Pharmacy Public Health

House resolution provisions

Identified Gains
  • Pharmacist service providers
  • Pharmacy business owners
  • Medicare beneficiaries
  • Rural Medicare patients
  • Public health agencies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Medicare beneficiaries:
Public health agencies:
Rural Medicare patients:
Pharmacy business owners:
Pharmacist service providers:
Identified Costs
  • Medicare Part B program
  • Centers for Medicare and Medicaid Services
  • Pharmacists
  • Primary care physician practices
  • Medicare claims contractors
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Pharmacists:
Medicare Part B program:
Medicare claims contractors:
Primary care physician practices:
Centers for Medicare and Medicaid Services:

Legislative Progress

Reported
Introduced Committee Passed
May 21, 2026

Ordered to be Reported in the Nature of a Substitute …

May 21, 2026

Committee Consideration and Mark-up Session Held

May 1, 2025

Mr. Smith of Nebraska (for himself, Mr. Schneider, Mrs. Harshbarger, …

May 1, 2025

Referred to the Committee on Energy and Commerce, and in …

May 1, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
5 mentions across 1 clause
+3 positive -2 negative

Medicare Part B program, Medicare beneficiaries, Pharmacist service providers

Positive-direction: Medicare beneficiaries, Pharmacist service providers, Pharmacy business owners

Negative-direction: Medicare Part B program, Primary care physician practices

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Medicare Pharmacy Public Health
Actor Mappings
"cms"
→ Centers for Medicare and Medicaid Services
"secretary"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology